The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Comparison of Acute Kidney Injury During Treatment with Vancomycin in Combination with Piperacillin‐Tazobactam or Cefepime
Abstract
Study Objective: To evaluate the observed incidence of acute kidney injury (AKI) in adult patients receiving either piperacillin‐tazobactam and vancomycin or cefepime‐vancomycin for more than 48 hours. Design: Retrospective matched cohort. Setting: Large academic medical center. Patients: Adult patients without preexisting renal dysfunction admitted over an 8‐month time period who received either the combination of piperacillin‐tazobactam and vancomycin or cefepime‐vancomycin for more than 48 hours were evaluated for AKI, defined by the Acute Kidney Injury Network criteria. Measurements and Main Results: A total of 224 patients receiving either antimicrobial combination were evaluated for AKI. The incidence of AKI was significantly higher in the piperacillin‐tazobactam and vancomycin group (34.8%) compared with the cefepime‐vancomycin group (12.5%) in the unmatched analysis (p<0.0001). After adjusting for potential sources of bias through propensity score matched pairs and conditional logistic regression, piperacillin‐tazobactam and vancomycin combination therapy (p=0.003) was an independent predictor of AKI. There were no significant differences in time to AKI or hospital length of stay between groups. Conclusions: The results of this study suggest that there may be an association between piperacillin‐tazobactam and vancomycin combination therapy and increased incidence of AKI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rybak, M., Lomaestro, B., Rotschafer, J. C., Moellering, R., Craig, W., Billeter, M., Dalovisio, J. R., & Levine, D. P. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080434 · Cited by 1,795
Cited by
Rybak, M. J., Le, J., Lodise, T. P., Levine, D. P., Bradley, J. S., Liu, C., Mueller, B. A., Pai, M. P., Wong-Beringer, A., Rotschafer, J. C., et al. (2020) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxaa036 · Cited by 1,202
The Nephrotoxicity of Vancomycin
Filippone, E., Kraft, W., & Farber, J. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.726 · Cited by 416
Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: A cohort study.
Webb, B. J., Sorensen, J., Jephson, A., Mecham, I., & Dean, N. C. (2019) · European Respiratory Journal · doi:10.1183/13993003.00057-2019 · Cited by 164
Pan, K., Li, R., Li, Y., Ding, X., Li, X., & Lv, Q. (2025) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkae410 · Cited by 16
Metadata
- Authors
- Gomes, D. M., Smotherman, C., Birch, A., Dupree, L., Della Vecchia, B. J., Kraemer, D. F., & Jankowski, C. A.
- Venue
- Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Publisher
- Wiley
- Published
- 2014-04-18
- Volume
- 34
- Issue
- 7
- Pages
- 662-669
- ISSN
- 0277-0008 (ISSN-L)
- 1875-9114
- OpenAlex
- W1972725951
- Cited by
- 180
- References
- 1
- FWCI
- 15.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of Acute Kidney Injury During Treatment with Vancomycin in Combination with Piperacillin‐Tazobactam or Cefepime. https://app.cochat.ai/papers/10.1002/phar.1428
- The paper
- Gomes, D. M., Smotherman, C., Birch, A., Dupree, L., Della Vecchia, B. J., Kraemer, D. F., & Jankowski, C. A. (2014). Comparison of Acute Kidney Injury During Treatment with Vancomycin in Combination with Piperacillin‐Tazobactam or Cefepime. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1002/phar.1428
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.